These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 25813036)
1. Molecular classification of gastric adenocarcinoma: translating new insights from the cancer genome atlas research network. Sunakawa Y; Lenz HJ Curr Treat Options Oncol; 2015 Apr; 16(4):17. PubMed ID: 25813036 [TBL] [Abstract][Full Text] [Related]
2. Predictive value of WHO classification for PD-L1 and Her2/Neu expression and distinct associations with protein expression based classification in gastric carcinoma. Setia N; Ahn S; Han HS; Park DY; Lauwers GY Hum Pathol; 2019 Dec; 94():64-70. PubMed ID: 31676362 [TBL] [Abstract][Full Text] [Related]
3. Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability. Cho J; Lee J; Bang H; Kim ST; Park SH; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Kang WK; Kim S; Kim KM Oncotarget; 2017 Feb; 8(8):13320-13328. PubMed ID: 28076847 [TBL] [Abstract][Full Text] [Related]
4. Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients. Owen GI; Pinto MP; Retamal IN; Fernádez MF; Cisternas B; Mondaca S; Sanchez C; Galindo H; Nervi B; Ibañez C; Acevedo F; Madrid J; Peña J; Bravo ML; Maturana MJ; Cordova-Delgado M; Romero D; de la Jara N; Torres J; Rodriguez-Fernandez M; Espinoza M; Balmaceda C; Freire M; Gárate-Calderón V; Crovari F; Jimenez-Fonseca P; Carmona-Bayonas A; Zwenger A; Armisen R; Corvalan AH; Garrido M Medicine (Baltimore); 2018 Apr; 97(16):e0419. PubMed ID: 29668600 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive molecular characterization of gastric adenocarcinoma. Cancer Genome Atlas Research Network Nature; 2014 Sep; 513(7517):202-9. PubMed ID: 25079317 [TBL] [Abstract][Full Text] [Related]
6. [New molecular classification of colorectal cancer, pancreatic cancer and stomach cancer: Towards "à la carte" treatment?]. Dreyer C; Afchain P; Trouilloud I; André T Bull Cancer; 2016; 103(7-8):643-50. PubMed ID: 27345450 [TBL] [Abstract][Full Text] [Related]
7. Molecular classification and intratumoral heterogeneity of gastric adenocarcinoma. Kuwata T Pathol Int; 2024 Jun; 74(6):301-316. PubMed ID: 38651937 [TBL] [Abstract][Full Text] [Related]
8. [Molecular Subtypes of Gastric Cancer]. Hatogai K; Doi T Gan To Kagaku Ryoho; 2016 Mar; 43(3):281-5. PubMed ID: 27067842 [TBL] [Abstract][Full Text] [Related]
9. Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation. Speck O; Tang W; Morgan DR; Kuan PF; Meyers MO; Dominguez RL; Martinez E; Gulley ML Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):633-45. PubMed ID: 25517873 [TBL] [Abstract][Full Text] [Related]
10. Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma. Tan P; Yeoh KG Gastroenterology; 2015 Oct; 149(5):1153-1162.e3. PubMed ID: 26073375 [TBL] [Abstract][Full Text] [Related]
11. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery. Ramos MFKP; Pereira MA; de Mello ES; Cirqueira CDS; Zilberstein B; Alves VAF; Ribeiro-Junior U; Cecconello I World J Clin Oncol; 2021 Aug; 12(8):688-701. PubMed ID: 34513602 [TBL] [Abstract][Full Text] [Related]
12. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil. Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942 [TBL] [Abstract][Full Text] [Related]
13. Predictive biomarkers along gastric cancer pathogenetic pathways. Panarese I; De Vita F; Ronchi A; Romano M; Alfano R; Di Martino N; Zito Marino F; Ferraraccio F; Franco R Expert Rev Anticancer Ther; 2017 May; 17(5):417-425. PubMed ID: 28277834 [TBL] [Abstract][Full Text] [Related]
14. High-throughput Protein and mRNA Expression-based Classification of Gastric Cancers Can Identify Clinically Distinct Subtypes, Concordant With Recent Molecular Classifications. Ahn S; Lee SJ; Kim Y; Kim A; Shin N; Choi KU; Lee CH; Huh GY; Kim KM; Setia N; Lauwers GY; Park DY Am J Surg Pathol; 2017 Jan; 41(1):106-115. PubMed ID: 27819872 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients. Kawazoe A; Kuwata T; Kuboki Y; Shitara K; Nagatsuma AK; Aizawa M; Yoshino T; Doi T; Ohtsu A; Ochiai A Gastric Cancer; 2017 May; 20(3):407-415. PubMed ID: 27629881 [TBL] [Abstract][Full Text] [Related]
17. [Gastric tumors and tumor precursors]. Röcken C Pathologe; 2017 Mar; 38(2):75-86. PubMed ID: 28084526 [TBL] [Abstract][Full Text] [Related]
18. Genomics Study of Gastric Cancer and Its Molecular Subtypes. Yuen ST; Leung SY Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784 [TBL] [Abstract][Full Text] [Related]
19. Gastric Cancer Genomics: Advances and Future Directions. Katona BW; Rustgi AK Cell Mol Gastroenterol Hepatol; 2017 Mar; 3(2):211-217. PubMed ID: 28275688 [TBL] [Abstract][Full Text] [Related]
20. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer. Lim B; Kim JH; Kim M; Kim SY World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]